A Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease Dementia

I8D-MC-AZFD -

Trial Summary

Age Range
≥55 years
Conditions the trial is for
Alzheimer's Disease
What the trial is testing?
LY3314814
Could I receive a Placebo?
No
Enrollment Goal
421
Trial Dates
Mar 15, 2017 - Oct 2, 2018
How long will I be in the trial?
Trial Phase
III

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.